Newsmeme!
Discover News you didn't know existed
CytoSolv Inc., a biotech startup in Providence, R.I., has taken in $500,000 in seed-stage funding from the Slater Technology Fund, Rhode Island’s state-backed venture capital fund.
An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb. 7 issue of Nature Medicine. Serotonin in the gut has been shown in recent research to stall bone formation. The finding could lead to new ...
Experimental agent targets serotonin in the gut, triggering bone formation.
Title: Drug Cures Osteoporosis in Mice Category: Health News Created: 2/8/2010 8:10:00 AM Last Editorial Review: 2/8/2010
Title: Serotonin May Be a Key to Treat Osteoporosis Category: Health News Created: 2/8/2010 11:53:00 AM Last Editorial Review: 2/8/2010 11:53:01 AM
An international team led by researchers from Columbia University Medical Center was able to cure osteoporosis in mice and rats through a daily dose of an experimental compound that inhibits serotonin synthesis in the gut. Recent research has already shown that serotonin in the gut stalls bone formation. This latest finding could lead to novel therapies that build new bone; most current ...
A once-a-day pill has shown promising results in rebuilding the bone structure in rodents suffering from severe osteoporosis, a new study finds.
Finding, in animal model, offers proof of principle that inhibiting serotonin in the gut could become a novel treatment for 10s of millions of osteoporosis sufferersAn investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical ...
MONDAY, Feb. 8 (HealthDay News) -- An experimental drug that inhibits serotonin in the gut cured osteoporosis in lab mice and rats, a new study has found.
VANCOUVER, British Columbia -- biOasis Technologies Inc. is pleased to announce that Mr. Hugh MacNaught has accepted the position of Executive Vice President with the Company.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |